Seres Therapeutics
MCRB
MCRB
152 hedge funds and large institutions have $1.85B invested in Seres Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 45 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 152 → 152 (0)
12% less capital invested
Capital invested by funds: $2.12B → $1.85B (-$264M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
152
Holding in Top 10
1
Calls
$35.3M
Puts
$5.01M
Top Buyers
| 1 | +$76.1M | |
| 2 | +$20.6M | |
| 3 | +$19.4M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.9M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$7.21M |
Top Sellers
| 1 | -$38.8M | |
| 2 | -$12.9M | |
| 3 | -$11.9M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$9.59M |
| 5 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$8.82M |